(Q48400779)

English

Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study.

scientific article published on 15 May 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17505051

Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17505051

0 references

John Edward Blundell

2

object named as

John E Blundell

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

author name string

Steven R Smith

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17505051

Colleen Burns

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17505051

Cinzia Ellero

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17505051

Brock E Schroeder

5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17505051

Nicole C Kesty

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17505051

Kim S Chen

7

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17505051

Amy E Halseth

8

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17505051

Cameron W Lush

9

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17505051

Christian Weyer

10

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17505051

publication date

15 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17505051

American Journal of Physiology - Endocrinology and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17505051

293

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17505051

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17505051

E620-7

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17505051

The gut and energy balance: visceral allies in the obesity wars

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

Is susceptibility to weight gain characterized by homeostatic or hedonic risk factors for overconsumption?

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

Tests of adipsia and conditioned taste aversion following the intrahypothalamic injection of amylin.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

Gastrointestinal hormones regulating appetite

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

Central regulators of food intake

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

The pharmacology of human appetite expression.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

Gut peptides and the regulation of appetite.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

Corticostriatal-hypothalamic circuitry and food motivation: integration of energy, action and reward

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

Pramlintide for the treatment of insulin-requiring diabetes mellitus: rationale and review of clinical data

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

Amylinergic control of food intake

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

Pancreatic amylin as a centrally acting satiating hormone

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated subjects with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

The anorectic hormone amylin contributes to feeding-related changes of neuronal activity in key structures of the gut-brain axis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

Comparison of Fos induced in rat brain by GLP-1 and amylin.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

Central amylin signaling and the regulation of energy homeostasis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

Inhibition of central amylin signaling increases food intake and body adiposity in rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

Acute 3rd-ventricular amylin infusion potently reduces food intake but does not produce aversive consequences

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

Pancreatic signals controlling food intake; insulin, glucagon and amylin

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

The gut and regulation of body weight

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00217.2007

21 January 2018

Identifiers

10.1152/AJPENDO.00217.2007

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17505051

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17505051

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48400779&oldid=928912634"